spacer
home > pmps > autumn 2003 > production of blow fill seal container closure systems for pharmaceutical application
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Production of Blow Fill Seal Container Closure Systems for Pharmaceutical Application

Blow fill seal containers are a commonly used system for pharmaceutical infusion and injection solution application, and blow fill seal packaging systems are customer specific machines. An important characteristic of the blow fill seal process is the sterile and pyrogenfree moulding of bottles or ampoules directly from the extruded PE or PP in water-cooled blow moulds with an immediate sterile filling of product, and followed by a hermetic sealing of the container in one step and under aseptic conditions in the same machine. This assures high reliability as well as product security. The flexible design of the containers, which combine integrated moulding of the head closure and in-mould coding, allows for a high degree of convenience in user handling. The technology is well-known for its very low particulate matter production and neutrality to the filling product.

The materials used to manufacture blow fill seal containers are primary packaging materials suitable for storing infusion solutions until they are administered. A closure system which will make the connection between the bottle and the infusion set or a syringe is essential. The sealing between the infusion set and the bottle is important for the closure system, as is the handling of the opening system. Additionally, an issue to be aware of is the rubber or TPE disc implemented in the bottle pack cap, which acts as a barrier product for the patient. There are many different systems on the market, and this article will concentrate on the standard Euro bottle pack cap according to the ISO 15759, exploring different types of rubber discs.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Fries Holger, Production Manager for Pharmaceutical Products at Braun GmbH

Holger Fries holds a REFA in Engineering from Karlsruhe University in Germany. He began his career as Production Manager at Freudenberg Pohl in Karlsruhe for primary and secondary packaging plastic materials for pharmaceutical use. He is now Production Manager of pharmaceutical products at Braun GmbH in Bahlingen.

spacer
Holger Frie
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Breakthrough in the global battle against polio: AJ Vaccines granted WHO prequalification for new polio vaccine

Despite ongoing concerted efforts to eradicate polio, it appears to be on the rise again with more cases registered in 2019 than 2018. Looking ahead, AJ Vaccines’ dose sparing technology provides a significant opportunity to expand supply, with the potential to deliver up to 100 million doses over the five-year period 2020-2024 to help meet the currently unmet global demand for inactivated polio vaccines.
More info >>

White Papers

Delivering Fit For Purpose Biomanufacturing CHO Cell Lines

Fujifilm Diosynth Biotechnologies

The challenge during mammalian cell line development is to identify and isolate stable, high expressing cell lines producing product with the appropriate critical product quality attributes rapidly, reproducibly and with relative ease. Obtaining a host cell line that inherently exhibits desirable biomanufacturing attributes can therefore have a significantly positive effect on the identification of recombinant cell lines with desired traits during cell line development screens. In this study, we demonstrate that it is possible to exploit intrinsic heterogeneity within host cell populations and identify host cell lines which are more “fit for purpose”.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement